CareLit Fachartikel

Serum gamma-glutamyl transferase (GGT) levels within the normal range are associated with a high SVR rate of 85% in treatment-naive patients undergoing Boceprevir triple therapy f…

P Buggisch, H Löhr, G Teuber, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthöft, A Herrmann, M Hoesl, U Naumann, E Zehnter, D Hartmann, B Dreher, M Bilzer · Zeitschrift für Gastroenterologie · 2015 · Heft 08

Dokument
987287
CareLit-ID
Jahr
2015
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Zeitschrift für Gastroenterologie
Autor:innen
P Buggisch, H Löhr, G Teuber, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthöft, A Herrmann, M Hoesl, U Naumann, E Zehnter, D Hartmann, B Dreher, M Bilzer
Ausgabe
Heft 08 / 2015
Seiten
–
Erschienen: 2015-08-18 00:00:00
ISSN
0044-2771

Zusammenfassung

Background: A considerable number of patients (pts) with chronic HCV G1 infection will present with elevated serum GGT levels. However, the impact of GGT elevation on virologic response to boceprevir (BOC) triple therapy has not been investigated until now and was therefore the aim of the present interim analysis of the German NOVUS observational study. Methods: From April 2012 until January 2014, 536 pts with G1 infection were recruited in the ongoing NOVUS study by 97 practices and hospitals in Germany. Pts were treated with pegylated interferons (PegIFN) and ribavirin (RBV) together with BOC for 24 to 44 week…

Schlagworte

Zeitschrift für Gastroenterologie